January 13, 2022

Join our next webinar: Introduction to Brand Protection: Safeguarding Patients and Products from Illicit Trade Risk

The details What: online webinarWhen: 26th January 2022, 14:00 GMT / 15:00 CET timeCost: FreeRegister: https://register.gotowebinar.com/register/1146437005378726412
September 22, 2021


Managing EMVS EU-FMD alerts in a timely and GMP-compliant way is a legal obligation for every pharma manufacturer selling to the European market. Over two years […]
May 25, 2021

Download now avaliable: Jazz Pharmaceuticals Health Check and Brand Risk Assessment Case Study

Putting patient safety first | How the Excellis Health Check and Brand Risk Assessment programme is helping pharma firms minimise security challenges In an age where […]
December 21, 2020

Highly sensitive Covid vaccine could be a test of resilience for the EU-FMD anti-counterfeiting elements

Article Updated 6th Jan A long winter… Just before the holidays we set the good news about the roll-out of COVID-19 vaccines gathering speed in context […]